FastMarket.news

U.S.-China Trade Truce Sends Funko's Stock Skyrocketing

Published 1 hours agoFNKO
U.S.-China Trade Truce Sends Funko's Stock Skyrocketing

Funko's stock has seen a remarkable surge following the announcement of a 90-day trade truce between the U.S. and China, which includes significant reductions in tariffs. The U.S. has agreed to cut additional tariffs on Chinese imports from 145% down to 30%, while China will lower tariffs on U.S. goods from 125% to just 10%. These temporary measures are intended to last for 90 days, according to Reuters.


The trade truce has sparked a significant rally in U.S. markets. The S&P 500 has climbed by 2.6%, the Dow Jones jumped 957 points, marking a 2.3% increase, and the Nasdaq rose by an impressive 3.6%, as reported by AP News. This positive market response highlights investor optimism as the trade tensions show signs of easing.


Toy manufacturers like Funko, who previously struggled with high tariffs that led to price hikes and complicated supply chains, are expected to benefit from the reduced tariffs. This truce alleviates some of the pressures faced by the industry, offering a sense of relief and potential stability for companies heavily reliant on international trade.

Share this article

Recent Articles

GM Appoints Sterling Anderson as Executive VP and Chief Product Officer

GM Appoints Sterling Anderson as Executive VP and Chief Product Officer

15 minutes agoGM

General Motors has announced the appointment of Sterling Anderson as its new Executive Vice President of Global Product and Chief Product Officer, effective June 2, 2025. Anderson, who co-founded the self-driving company Aurora, will take on this leadership role to guide the entire product lifecycle of GM's gasoline and electric vehicles, including aspects like hardware, software, and user experience. In his new position, Anderson will report directly to GM President Mark Reuss and will be based at the company's Mountain View Tech Center in California. His extensive experience includes co-founding Aurora in 2017, a company focused on self-driving trucks, and leading major projects at Tesla, such as the Model X program and the Autopilot team, according to Reuters. This leadership change is part of GM's strategic pivot from investing in its costly Cruise robotaxi business toward enhancing its autonomous capabilities in personal vehicles. The company aims to expand the deployment of its Super Cruise hands-free driving technology, aligning with Anderson's expertise and previous achievements.

NRG Energy to Acquire LS Power Assets for $12 Billion

NRG Energy to Acquire LS Power Assets for $12 Billion

30 minutes agoNRG

NRG Energy has announced a major deal involving the acquisition of power generation assets from LS Power valued at $12 billion. The deal will consist of $6.4 billion in cash, $2.8 billion in stock, and the assumption of $3.2 billion in net debt. This acquisition includes 18 natural gas-fired facilities with a total capacity of 13 gigawatts, along with a virtual power plant, effectively doubling NRG's generation capacity to 25 gigawatts, as reported by Reuters. Financially, the acquisition is poised to close in the first quarter of 2026 and is expected to be immediately accretive to NRG's earnings per share (EPS). The company has raised its long-term EPS growth forecast from 10% to 14% and anticipates approximately $400 million in tax benefits from the deal. This development has already had a positive impact on NRG's stock, which saw a rise of more than 6% in premarket trading after the announcement. NRG's strategic move comes in response to projected record-high electricity demand fueled by advances in artificial intelligence, the proliferation of cryptocurrency data centers, and increased electrification in heating and transportation. CEO Larry Coben has described the current era as the start of a "power demand supercycle." This acquisition aligns with NRG's broader vision to capitalize on these demand trends, reinforcing its position in the evolving energy landscape.

Earnings Surprise: Hugo Boss, Novartis, and Others Exceed Market Expectations

Earnings Surprise: Hugo Boss, Novartis, and Others Exceed Market Expectations

45 minutes agoSLAB

Several major companies have released their Q1 2025 earnings, surprising market participants with varied financial performances. Hugo Boss, for instance, reported revenues of €999 million, slightly below the previous year's €1.01 billion but above analyst forecasts of €974 million. Notably, their EBIT hit €61 million, outstripping expectations of €50 million, leading to an 8.4% rise in shares, according to Reuters. Elsewhere, Novartis exceeded analyst expectations with a 22% increase in adjusted net income, reaching $4.48 billion, fueled by strong sales from drugs like Leqvio and Kisqali. This led to the company raising its full-year earnings forecast. Additionally, Novartis announced an ambitious $23 billion investment to expand its U.S. facilities. General Motors also posted robust Q1 results with profits of $2.78 billion, outpacing projections, and revealed plans to reassess its yearly guidance due to potential auto tariff changes, as reported by AP News. Other companies making waves include Siemens Healthineers, which confirmed a revenue increase of 5.9% to €5.48 billion, beating forecasts. Meanwhile, Heico Corporation saw its stock surge by nearly 14% after surpassing earnings expectations with EPS reaching $1.20. On the tech front, Qualcomm reported revenues of $11.67 billion, spurred by growth in handsets and automotive sectors. Lastly, Disney's Direct-to-Consumer segment significantly boosted its financial results, with EPS at $1.76, topping forecasts. These earnings provide crucial insights into the strategic directions and financial health of these companies, impacting investor decisions.

Aurinia Pharmaceuticals Projects 2025 Revenue of up to $260 Million Amid Strategic Restructuring

Aurinia Pharmaceuticals Projects 2025 Revenue of up to $260 Million Amid Strategic Restructuring

1 hours agoAUPH

Aurinia Pharmaceuticals has announced its revenue guidance for 2025, projecting a range between $250 million and $260 million. This announcement comes as the company undergoes significant operational changes aimed at improving efficiency and reducing costs, as reported by Webull. One of the highlights from Aurinia's recent financial performance is the robust growth in LUPKYNIS sales, which resulted in a 36% increase in net product revenue year-over-year for the third quarter of 2024. To further enhance its operational efficiency, Aurinia is implementing a strategic restructuring plan that includes a workforce reduction by approximately 45%. This effort is expected to save the company over $40 million annually in cash-based operating expenses, according to information from Aurinia Pharmaceuticals' official website. In addition to financial updates, Aurinia is focusing on its pipeline development. The company initiated a Phase 1 study of AUR200, a promising dual inhibitor targeting autoimmune disease-related cytokines, in September 2024. Investors are keeping an eye on the results expected in the first half of 2025. Meanwhile, Aurinia's share price was recently at $8.37, marking a 4.63% rise from the prior close, demonstrating a positive market reaction.